Paul W. Glimcher

Paul W. Glimcher holds the Julius Silver, Rosyln S. Silver and Enid Silver Winslow Chair of Neural Science at New York University (NYU) and is Professor of Neuroscience and Physiology at NYU’s Langone School of Medicine. He is also Professor of Economics and Psychology at NYU. He is also the chief Executive Officer of Data Cubed LLC, a pioneering healthcare technology company that collects accurate real-world data and electronic Clinical Outcome Assessments eCOA solutions tailored to everything from remote patient engagement to virtual clinical trials. By tapping into what makes humans human, Data Cubed is changing how healthcare approaches big data to create a healthier world. Find out more by visiting


FDA's $100 Million RWE Project: Making It All It Can Be

FDA's proposal to build a modern system to gather real-world evidence (RWE) from about 10 million individuals could have profound implications, but it will realize its potential only if FDA takes a more expansive view of what RWE can be, writes Paul Glimcher.